STIM Logo

Neuronetics, Inc. (STIM) 

NASDAQ
Market Cap
$44.58M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
203 of 960
Rank in Industry
10 of 52

Largest Insider Buys in Sector

STIM Stock Price History Chart

STIM Stock Performance

About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of …

Insider Activity of Neuronetics, Inc.

Over the last 12 months, insiders at Neuronetics, Inc. have bought $362,788 and sold $741,088 worth of Neuronetics, Inc. stock.

On average, over the past 5 years, insiders at Neuronetics, Inc. have bought $399,359 and sold $2.35M worth of stock each year.

Highest buying activity among insiders over the last 12 months: CASCELLA ROBERT (director) — $832,980. MUIR GLENN P (director) — $170,257.

The last purchase of 100,000 shares for transaction amount of $75,000 was made by CASCELLA ROBERT (director) on 2024‑09‑12.

List of Insider Buy and Sell Transactions, Neuronetics, Inc.

2024-10-08SaleEVP, CFO and Treasurer
1,368
0.0047%
$0.82$1,122+19.77%
2024-10-08SaleEVP, GC, CCO and CS
1,541
0.0053%
$0.82$1,264+19.77%
2024-09-12Purchasedirector
100,000
0.3345%
$0.75$75,000+28.78%
2024-09-05Purchasedirector
25,000
0.0843%
$0.80$20,000+20.81%
2024-08-29Purchasedirector
12,224
0.0404%
$0.85$10,390+8.82%
2024-08-28Purchasedirector
12,776
0.0408%
$0.85$10,860+4.76%
2024-08-20Purchasedirector
25,000
0.0809%
$1.00$25,000-8.85%
2024-08-19Purchasedirector
4,000
0.0149%
$1.14$4,560-7.20%
2024-08-16Purchasedirector
35,000
0.165%
$1.06$37,100-4.72%
2024-08-15Purchasedirector
35,000
0.137%
$0.88$30,8000.00%
2024-08-14Purchasedirector
35,000
0.123%
$0.79$27,6500.00%
2024-08-14Purchasedirector
25,171
0.084%
$0.75$18,8780.00%
2024-07-18SalePresident and CEO
24,162
0.0805%
$1.90$45,908-49.26%
2024-07-17SalePresident and CEO
11,687
0.0384%
$1.97$23,023-51.75%
2024-07-16SalePresident and CEO
12,075
0.0444%
$1.91$23,063-51.62%
2024-06-06Purchasedirector
50,000
0.1684%
$2.05$102,550-50.25%
2024-02-29SaleEVP, GC, CCO and CS
6,026
0.0207%
$2.94$17,716-38.33%
2024-02-28SaleEVP, CFO and Treasurer
3,985
0.0147%
$3.16$12,593-37.04%
2024-02-28SaleEVP, GC, CCO and CS
22,377
0.0827%
$3.16$70,711-37.04%
2024-02-27SaleEVP, CFO and Treasurer
21,272
0.0756%
$3.33$70,836-42.46%

Insider Historical Profitability

16.91%
Furlong StephenEVP, CFO and Treasurer
497408
1.551%
$1.39224+50.62%
CASCELLA ROBERTdirector
453098
1.4129%
$1.3990<0.0001%
MACAN WILLIAM ANDREWEVP, GC, CCO and CS
402792
1.256%
$1.39125+123.41%
MUIR GLENN Pdirector
289818
0.9037%
$1.3960<0.0001%
CANNELL CAPITAL LLC10 percent owner
3127819
9.7533%
$1.391817+18.48%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Archon Capital Management Llc$12.08M8.462.54M0%+$00.27
Cannell Capital LLC$11.73M8.212.46M-11.05%-$1.46M2.76
Divisadero Street Capital Management Lp$7.33M5.131.54MNew+$7.33M1.72
The Vanguard Group$6.19M4.331.3M-3.93%-$253,370.07<0.0001
Silvercrest Asset Management Group Inc$5.61M3.931.18M+4.61%+$246,953.540.04
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.